RPG Life Sciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 7.55% vs 18.05% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 40.17% vs -77.60% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 10.04% vs 39.15% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is -7.69% vs -27.78% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of RPG LifeScience. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

181.68

60.30

121.38

201.29%

Other Operating Income

0.00

Total Operating income

181.68

60.30

121.38

201.29%

Raw Material Cost

32.72

11.19

21.53

192.40%

Purchase of Finished goods

38.78

0.00

38.78

(Increase) / Decrease In Stocks

-4.92

0.96

-5.88

-612.50%

Employee Cost

36.16

21.74

14.42

66.33%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

39.91

22.00

17.91

81.41%

Total Expenditure (Excl Depreciation)

142.65

55.89

86.76

155.23%

Operating Profit (PBDIT) excl Other Income

39.03

4.41

34.62

785.03%

Other Income

4.54

11.17

-6.63

-59.36%

Operating Profit (PBDIT)

43.57

15.58

27.99

179.65%

Interest

0.12

20.61

-20.49

-99.42%

Exceptional Items

11.22

0.00

11.22

Gross Profit (PBDT)

54.67

-5.03

59.70

1,186.88%

Depreciation

5.22

15.79

-10.57

-66.94%

Profit Before Tax

49.45

-20.82

70.27

337.51%

Tax

12.60

-7.22

19.82

274.52%

Provisions and contingencies

0.00

Profit After Tax

36.85

-13.60

50.45

370.96%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

36.85

-13.60

50.45

370.96%

Equity Capital

13.23

31.36

-18.13

-57.81%

Face Value

8.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

22.28

-0.87

23.15

2,660.92%

Diluted Earnings per share

22.28

-0.87

23.15

2,660.92%

Operating Profit Margin (Excl OI)

21.48%

7.31%

0.00

14.17%

Gross Profit Margin

30.09%

-8.34%

0.00

38.43%

PAT Margin

20.28%

-22.55%

0.00

42.83%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 181.68 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 7.55% vs 18.05% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 5.50% vs 12.13% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 36.85 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 40.17% vs -77.60% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 777.38% vs -83.76% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 39.03 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 10.04% vs 39.15% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -15.02% vs 23.17% in Sep 2024

Quarterly - Interest

Interest 0.12 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -7.69% vs -27.78% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -29.41% vs 70.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 21.48%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024